(S (NP (NN Prostate) (NN brachytherapy)) (VP (VBZ involves) (S (VP (VBG implanting) (NP (NP (NP (NP (JJ radioactive) (NNS seeds)) (-LRB- -LRB-) (NP (NP (NN I125)) (PP (IN for) (NP (NN instance)))) (-RRB- -RRB-)) (PP (ADVP (RB permanently)) (IN in) (NP (NP (DT the) (NN gland)) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (VBN localized) (NN prostate) (NNS cancers)))))))) (, ,) (ADVP (FW e.g.)) (, ,) (NP (NP (NML (NN cT1c) (HYPH -) (NN T2a)) (NN N0) (NN M0)) (PP (IN with) (NP (JJ good) (JJ prognostic) (NNS factors)))))))) (. .))
(S (NP (NP (NN Treatment) (NN planning) (CC and) (NN seed)) (VP (VBG implanting))) (VP (VBP are) (ADJP (ADVP (RBS most) (RB often)) (VBN based) (PP (IN on) (NP (NP (DT the) (JJ intensive) (NN use)) (PP (IN of) (NP (JJ transrectal) (NN ultrasound) (PRN (-LRB- -LRB-) (NP (NN TRUS)) (-RRB- -RRB-)) (NN imaging))))))) (. .))
(S (NP (DT This)) (VP (VBZ is) (RB not) (ADJP (JJ easy)) (SBAR (IN because) (S (NP (NN prostate) (NN visualization)) (VP (VBZ is) (ADJP (JJ difficult) (PP (IN in) (NP (DT this) (NN imaging) (NN modality)))) (UCP (SBAR (ADVP (RB particularly)) (IN as) (S (VP (VBZ regards) (NP (NP (DT the) (NN apex)) (PP (IN of) (NP (DT the) (NN gland))))))) (CC and) (PP (IN from) (NP (DT an) (ADJP (AFX intra) (HYPH -) (CC and) (NN interobserver)) (NN variability) (NN standpoint)))))))) (. .))
(S (NP (NNP Radioactive) (NNS seeds)) (VP (VBP are) (VP (VBN implanted) (ADVP (RB inside)) (NP (NP (JJ open) (JJ interventional) (NNP MR) (NNS machines)) (PP (IN in) (NP (DT some) (NNS centers)))))) (. .))
(S (SBAR (IN Since) (S (NP (NNP MRI)) (VP (VBD was) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (JJ sensitive) (CC and) (JJ specific)) (PP (IN for) (NP (NN prostate) (NN imaging))) (SBAR (IN whilst) (S (NP (JJ open) (NNP MR)) (VP (VP (VBZ is) (ADJP (JJ prohibitive) (PP (IN for) (NP (JJS most) (NNS centers))))) (CC and) (VP (VBZ makes) (NP (JJ surgical) (NNS procedures)) (S (ADJP (RB very) (JJ complex)))))))))))))) (, ,) (NP (DT this) (NN work)) (VP (VBZ suggests) (S (VP (VBG bringing) (NP (DT the) (NNP MR)) (ADVP (RB virtually)) (PP (IN in) (NP (NP (DT the) (NN operating) (NN room)) (PP (IN with) (NP (NN MRI) (HYPH /) (NN TRUS) (NNS data) (NN fusion)))))))) (. .))
(S (NP (DT This)) (VP (VBZ involves) (S (VP (VBG providing) (NP (NP (DT the) (NN physician)) (PP (IN with) (NP (NN bi-modality) (NNS images)))) (NP (NP (-LRB- -LRB-) (NN TRUS) (CC plus) (NN MRI) (-RRB- -RRB-)) (VP (VBN intended) (S (VP (TO to) (VP (VB improve) (NP (NN treatment) (NN planning)) (PP (IN from) (NP (DT the) (NML (NNS data) (NN registration)) (NN stage))))))))))) (. .))
(S (NP (DT The) (NN paper)) (VP (VBZ describes) (NP (NP (DT the) (NN method)) (VP (VBN developed) (CC and) (VBN implemented) (PP (IN in) (NP (DT the) (NN PROCUR) (NN system)))))) (. .))
(S (NP (NNS Results)) (VP (VBP are) (VP (VBN reported) (PP (IN for) (NP (NP (DT a) (NN phantom)) (CC and) (NP (NP (JJ first) (NN series)) (PP (IN of) (NP (NNS patients)))))))) (. .))
(S (NP (NNP Phantom) (NNS experiments)) (VP (VBD helped) (VP (VB characterize) (NP (NP (DT the) (NN accuracy)) (PP (IN of) (NP (DT the) (NN process)))))) (. .))
(S (NP (NN Patient) (NNS experiments)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (S (VP (VBG using) (NP (NP (NN MRI) (NNS data)) (VP (VBN linked) (PP (IN with) (NP (NN TRUS) (NN data))))))) (VP (VBZ improves) (NP (NP (NN TRUS) (NN image) (NN segmentation)) (PP (ADVP (RB especially)) (VBG regarding) (NP (NP (DT the) (NN apex) (CC and) (NN base)) (PP (IN of) (NP (DT the) (NN prostate))))))))))) (. .))
(S (NP (DT This)) (VP (VP (MD may) (ADVP (RB significantly)) (VP (VB modify) (NP (NN prostate) (NN volume) (NN definition)))) (CC and) (VP (VBP have) (NP (NP (DT an) (NN impact)) (PP (IN on) (NP (NN treatment) (NN planning)))))) (. .))
